Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Herpesvirus 8”

181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 181 results

Not applicableActive Not RecruitingNCT03737734
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Large-scale testing (Phase 3)Study completedNCT01352117
What this trial is testing

Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma

Who this might be right for
HIV-1 InfectionKaposi's Sarcoma
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 192
Testing effectiveness (Phase 2)Study completedNCT00194467
What this trial is testing

Suppression of Oral HHV8 Shedding With Valganciclovir

Who this might be right for
Human Herpesvirus 8
University of Washington 32
Testing effectiveness (Phase 2)UnknownNCT03993106
What this trial is testing

SEphB4-HSA in Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
Vasgene Therapeutics, Inc 65
Testing effectiveness (Phase 2)Ended earlyNCT00020683
What this trial is testing

A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma

Who this might be right for
AIDS-related Kaposi SarcomaHIV Infection
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT00540566
What this trial is testing

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

Who this might be right for
Malignant MelanomaMerkel Cell CarcinomaBasal Cell Carcinoma+12 more
University of California, Irvine 113
Very early researchEnded earlyNCT02080416
What this trial is testing

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Who this might be right for
Non-Hodgkin LymphomaHodgkin LymphomaKaposi Sarcoma+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Not applicableNot Yet RecruitingNCT07696169
What this trial is testing

Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers

Who this might be right for
HIV (Human Immunodeficiency Virus)AIDSKaposi Sarcoma (KS)+7 more
Shenzhen Third People's Hospital 1,000
Not applicableStudy completedNCT00096538
What this trial is testing

Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 6
Early research (Phase 1)Study completedNCT00000660
What this trial is testing

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Ended earlyNCT01752569
What this trial is testing

Selumetinib in Patients With Kaposi's Sarcoma

Who this might be right for
AIDS-related Kaposi's Sarcoma
Sheffield Teaching Hospitals NHS Foundation Trust 19
Not applicableStudy completedNCT00695422
What this trial is testing

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

Who this might be right for
Aids-related MalignanciesLymphomaPrecancerous Condition+1 more
AIDS Malignancy Consortium 47
Testing effectiveness (Phase 2)Study completedNCT00005931
What this trial is testing

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

Who this might be right for
Sarcoma, KaposiHIV Infections
SUGEN 30
Testing effectiveness (Phase 2)Study completedNCT03296553
What this trial is testing

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Who this might be right for
Kaposi SarcomaHuman Immunodeficiency VirusImmune Reconstitution Syndrome
National Institute of Cancerología 40
Testing effectiveness (Phase 2)Study completedNCT00064142
What this trial is testing

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
AIDS-related Kaposi SarcomaRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Not applicableUnknownNCT05510973
What this trial is testing

Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi

Who this might be right for
Opportunistic Infections, HIV-RelatedCryptococcal InfectionsAIDS With Tuberculosis+2 more
Elizabeth Glaser Pediatric AIDS Foundation 700
Testing effectiveness (Phase 2)Study completedNCT00020449
What this trial is testing

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT01412515
What this trial is testing

A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma

Who this might be right for
Kaposi Sarcoma
Institut National de la Santé Et de la Recherche Médicale, France 11
Load More Results